Pronađeno: 1-8 / 8 radova

Autori: Odanovic Olga

>> Filter: Samo Article i Review

Naslov Vedolizumab clearance as a predictor of remission in inflammatory bowel disease: a real-world pharmacokinetic study (Meeting Abstract)
Autori Markovic S  Kralj Djordje  Knezevic-Ivanovski Tamara  Kalaba Ana  Odanovic Olga  Homsek Ana B  Svorcan Petar V  Vucicevic Katarina M 
Info JOURNAL OF CROHNS & COLITIS, (2025), vol. 19 br. , Suppl. _1, str. I1231-I1231
Ispravka ISI/Web of Science   Članak   Elečas   Rang časopisa  
Naslov Review and External Evaluation of Population Pharmacokinetic Models for Vedolizumab in Patients with Inflammatory Bowel Disease: Assessing Predictive Performance and Clinical Applicability (Article)
Autori Jovanovic Marija N  Homsek Ana B  Markovic Srdjan T  Kralj Djordje  Svorcan Petar V  Knezevic-Ivanovski Tamara  Odanovic Olga  Vucicevic Katarina M 
Info BIOMEDICINES, (2025), vol. 13 br. 1, str. -
Projekat Science Fund of the Republic of Serbia; [6777]
Ispravka ISI/Web of Science   Članak   Elečas   Rang časopisa  
Naslov Disease Clearence after Acute Severe Ulcerative Colitis episode: is it possible ? (Meeting Abstract)
Autori Markovic Srdjan T  Kralj Djordje  Mitrovic M  Knezevic-Ivanovski Tamara  Kalaba Ana  Odanovic Olga  Maksimovic B  Sreckovic Slobodan  Svorcan Petar V 
Info JOURNAL OF CROHNS & COLITIS, (2025), vol. 19 br. , Suppl. _1, str. i2065-i2065
Ispravka ISI/Web of Science   Članak   Elečas   Rang časopisa  
Naslov Vedolizumab Clearance as a Surrogate Marker for Remission in Inflammatory Bowel Disease Patients: Insights from Real-World Pharmacokinetics (Article)
Autori Markovic Srdjan T  Kralj Djordje  Svorcan Petar V  Knezevic-Ivanovski Tamara  Odanovic Olga  Obradovic Sanja  Homsek Ana B  Jovanovic Marija N  Savic Rada  Vucicevic Katarina M 
Info PHARMACEUTICS, (2024), vol. 16 br. 12, str. -
Projekat Science Fund of the Republic of Serbia; [6777]
Ispravka ISI/Web of Science   Članak   Elečas   Rang časopisa  
Naslov Determing factors that influence Vedolizumab Response in Inflammatory Bowel Diseases: A Prospective Study (Meeting Abstract)
Autori Knezevic Tamara  Dobrosavljevic A  Odanovic Olga  Sreckovic Slobodan  Kralj Djordje  Mitrovic M  Svorcan Petar V  Markovic Srdjan T 
Info JOURNAL OF CROHNS & COLITIS, (2024), vol. 18 br. , Suppl. 1, str. I1550-I1550
Ispravka ISI/Web of Science   Elečas   Rang časopisa  
Naslov Pharmacokinetics and clinical evaluation of vedolizumab based on real-life routine monitoring data in IBD patients (Meeting Abstract)
Autori Markovic Srdjan T  Kralj Djordje  Odanovic Olga  Homsek Ana B  Kalaba Ana  Svorcan Petar V  Vucicevic Katarina M 
Info JOURNAL OF CROHNS & COLITIS, (2023), vol. 17 br. , Suppl. 1, str. 925-925
Ispravka ISI/Web of Science   Elečas   Rang časopisa  
Naslov Immunity in patients with inflammatory bowel disease on biologic therapy after COVID, 19 vaccination (Meeting Abstract)
Autori Knezevic Tamara  Cujic Danica  Odanovic Olga  Kralj Djordje  Gnjatovic Marija Lj  Kalaba Ana  Vrinic-Kalem Dusica  Svorcan Petar V  Markovic Srdjan T 
Info JOURNAL OF CROHNS & COLITIS, (2022), vol. 16 br. , Suppl. 1, str. I349-I349
Ispravka ISI/Web of Science   Elečas   Rang časopisa   Citati: ISI/Web of Science  
Naslov Immunity in patients with inflammatory bowel disease on biologic therapy after COVID, 19 vaccination (Meeting Abstract)
Autori Knezevic Tamara  Cujic Danica  Odanovic Olga  Kralj Djordje  Gnjatovic Marija Lj  Kalaba Ana  Vrinic-Kalem Dusica  Svorcan Petar V  Markovic Srdjan T 
Info JOURNAL OF CROHNS & COLITIS, (2022), vol. 16 br. , Suppl. 1, str. I349-I349
Ispravka ISI/Web of Science   Elečas   Rang časopisa   Citati: ISI/Web of Science  
Ispis zapisa u formatu:TXT | BibTeX